drugset / Trial / NCT04569799
Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE
NaSingle-groupOpen-labelOther
Summary
The purpose of this research study is to find out if a different type of imaging study called contrast enhanced ultrasound (CEUS) is as good as, or better than CT or MRI in patients diagnosed with hepatocellular carcinoma (HCC) after receiving TACE treatment
Timeline
- Start
- 2020-10-14
- Primary completion
- 2022-10-11
- Completion
- 2022-10-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Lumason | Diagnostic / imaging agent | 2.4 ml | — |